177Lu-FC335

N/A

Report date: 2026/05/20 20:02:01

NME

Base Information

Drug Name177Lu-FC335

Drug Alias Name177Lu-FC335

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agent

Mechanisms of ActionPositron-emission tomography enhancersFibroblast activation protein alpha inhibitors

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesFindCure Biosciences (ZhongShan) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesFindCure Biosciences (ZhongShan) Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A